WHO says has no proof from US on ’speculative’ Wuhan lab claims, seeks data

US Secretary of State Mike Pompeo on Sunday said 'enormous evidence' backed up the claim that the virus started in a Wuhan laboratory, which China has vehemently denied

AFP
Updated5 May 2020, 01:24 AM IST
(Illustration: Reuters)
(Illustration: Reuters)

The World Health Organization said Monday that Washington had provided no evidence to support "speculative" claims by the US president that the new coronavirus originated in a Chinese lab.

"We have not received any data or specific evidence from the United States government relating to the purported origin of the virus -- so from our perspective, this remains speculative," WHO emergencies director Michael Ryan told a virtual briefing.

Scientists believe the killer virus jumped from animals to humans, emerging in China late last year, possibly from a market in Wuhan selling exotic animals for meat.

But US President Donald Trump, increasingly critical of China's management of the first outbreak, claims to have proof it started in a Wuhan laboratory.

And US Secretary of State Mike Pompeo on Sunday said "enormous evidence" backed up that claim, which China has vehemently denied.

"Like any evidence-based organisation, we would be very willing to receive any information that purports to the origin of the virus," Ryan said, stressing that this was "a very important piece of public health information for future control.

"If that data and evidence is available, then it will be for the United States government to decide whether and when it can be shared, but it is difficult for the WHO to operate in an information vacuum in that regard," he added.

Science at the centre

The UN health agency -- which has also faced scathing criticism from Trump over accusations it initially downplayed the seriousness of the outbreak to shield China -- has repeatedly said the virus clearly appears to have originated naturally from an animal source.

WHO expert Maria Van Kerkhove stressed during Monday's briefing that there were some 15,000 full genome sequences of the novel coronavirus available, and "from all of the evidence that we have seen... this virus is of natural origin".

While coronaviruses generally originate in bats, both Van Kerkhove and Ryan stressed the importance of discovering how the virus that causes COVID-19 crossed over to humans, and what animal served as an "intermediary host" along the way.

"We need to understand more about that natural origin, and particularly about intermediate hosts," Ryan said.

It was important to know "so that we can put in place the right public health and animal-human interface policies that will prevent this happening again", he stressed.

The WHO said last week it wanted to be invited to take part in Chinese investigations into the animal origins of the pandemic, which in a matter of months has killed nearly 250,000 people worldwide.

"We have offered, as we do with every case in every country, assistance with carrying out those investigations," Ryan said Monday.

"We can learn from Chinese scientists," he said.

But he warned that if questions about the virus origin were "projected as aggressive investigation of wrongdoing, than I believe that's much more difficult to deal with. That is a political issue.

"Science needs to be at the centre," he said.

"If we have a science-based investigation and a science-based enquiry as to what the origin species and the intermediate species are, then that will benefit everybody on the planet."

Catch all the Business News , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.

MoreLess
First Published:5 May 2020, 01:24 AM IST
Business NewsNewsWorldWHO says has no proof from US on ’speculative’ Wuhan lab claims, seeks data

Get Instant Loan up to ₹10 Lakh!

  • Employment Type

    Most Active Stocks

    Tata Steel share price

    147.55
    03:59 PM | 8 NOV 2024
    -3.35 (-2.22%)

    Tata Motors share price

    805.70
    03:58 PM | 8 NOV 2024
    -14.1 (-1.72%)

    Indian Hotels Company share price

    733.05
    03:51 PM | 8 NOV 2024
    49.45 (7.23%)

    Ashok Leyland share price

    222.00
    03:59 PM | 8 NOV 2024
    6.2 (2.87%)
    More Active Stocks

    Market Snapshot

    • Top Gainers
    • Top Losers
    • 52 Week High

    Page Industries share price

    47,987.80
    03:53 PM | 8 NOV 2024
    2882.3 (6.39%)

    National Aluminium Company share price

    238.70
    03:57 PM | 8 NOV 2024
    0.15 (0.06%)

    Federal Bank share price

    206.05
    03:29 PM | 8 NOV 2024
    0.05 (0.02%)

    Apollo Hospitals Enterprise share price

    7,409.05
    03:29 PM | 8 NOV 2024
    -15.55 (-0.21%)
    More from 52 Week High

    Aarti Industries share price

    474.75
    03:59 PM | 8 NOV 2024
    -40.3 (-7.82%)

    Signatureglobal India share price

    1,274.45
    03:29 PM | 8 NOV 2024
    -107.95 (-7.81%)

    Great Eastern Shipping Company share price

    1,200.50
    03:29 PM | 8 NOV 2024
    -90.45 (-7.01%)

    GMM Pfaudler share price

    1,282.90
    03:29 PM | 8 NOV 2024
    -92 (-6.69%)
    More from Top Losers

    Indian Hotels Company share price

    733.05
    03:51 PM | 8 NOV 2024
    49.45 (7.23%)

    Vijaya Diagnostic Centre share price

    1,098.90
    03:29 PM | 8 NOV 2024
    71.45 (6.95%)

    Motilal Oswal Financial Services share price

    996.05
    03:59 PM | 8 NOV 2024
    61.85 (6.62%)

    One 97 Communications share price

    848.15
    03:58 PM | 8 NOV 2024
    52.35 (6.58%)
    More from Top Gainers

    Recommended For You

      More Recommendations

      Gold Prices

      • 24K
      • 22K
      Bangalore
      79,485.00910.00
      Chennai
      79,491.00910.00
      Delhi
      79,643.00910.00
      Kolkata
      79,495.00910.00

      Fuel Price

      • Petrol
      • Diesel
      Bangalore
      102.92/L0.00
      Chennai
      100.80/L0.00
      Kolkata
      104.95/L0.00
      New Delhi
      94.77/L0.00

      Popular in News

        HomeMarketsPremiumInstant LoanMint Shorts